Overview

Harm Reduction With Pharmacotherapy (HaRP)

Status:
Completed
Trial end date:
2019-06-30
Target enrollment:
Participant gender:
Summary
The goal of this study is to test the efficacy of extended-release naltrexone and harm reduction counseling in reducing alcohol-related harm among homeless people with alcohol dependence.
Phase:
Phase 2
Details
Lead Sponsor:
University of Washington
Collaborators:
Alkermes, Inc.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)